A science piece on how peptides taken by mouth can survive the gut and still reach their targets, a key hurdle for drugs like oral GLP-1s.
Recap by typeshit. Post by The Tribune on X.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Dr. Lorenc says patients ask him about peptides every week, and he pushes back on the idea that buzz on social feeds means the evidence is there.
Medscape reports the finding on nail separation in GLP-1 users. Experts quoted call for more research and caution doctors against alarming patients.
Loading…